These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3905652)

  • 1. Growth hormone in obesity and diabetes: inappropriate hypothalamic control of secretion.
    Martin RJ; Jeanrenaud B
    Int J Obes; 1985; 9 Suppl 1():99-104. PubMed ID: 3905652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate counter-regulatory hormone levels in insulin treated diabetes.
    Danowski TS; Fisher ER; Kozak W; Bahl VK; Stephan T; Nolan S; Ahmad U
    PDM; 1976; 7(9-12)8(1-8):7-16. PubMed ID: 1052833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate counter-regulatory hormone levels in insulin treated diabetes.
    Danowski TS; Fisher ER; Kozak W; Bahl VK; Stephan T; Nolan S; Ahmad U
    Behav Neuropsychiatry; 1976 Apr-1977 Mar; 8(1-12):6-15. PubMed ID: 1052263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of obesity-inducing ventromedial hypothalamic lesions on pulsatile growth hormone and insulin secretion: evidence for the existence of a growth hormone-releasing factor.
    Eikelboom R; Tannenbaum GS
    Endocrinology; 1983 Jan; 112(1):212-9. PubMed ID: 6128221
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats.
    Kappeler L; Zizzari P; Grouselle D; Epelbaum J; Bluet-Pajot MT
    J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the blood levels of insulin and growth hormone in healthy adolescents, adolescents with excessive weight and with hereditary loading with regard to diabetes mellitus].
    Morozova TP
    Probl Endokrinol (Mosk); 1977; 23(4):3-7. PubMed ID: 905257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Somatotropic hormone, diabetes and diabetic angiopathy].
    Dobrev DG
    Vutr Boles; 1979; 18(5):21-7. PubMed ID: 390884
    [No Abstract]   [Full Text] [Related]  

  • 10. Circadian rhythm of plasma growth hormone, cortisol and insulin in obese and diabetic children.
    Di Natale B; Devetta M; Rossi L; Garlaschi C; Caccamo A; Del Guercio MJ; Chiumello G
    Helv Paediatr Acta; 1973 Dec; 28(6):591-602. PubMed ID: 4785154
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronobiological aspects of blood glucose regulation: a new scope for the study of diabetes mellitus.
    Gagliardino JJ; Hernandez RE; Rebolledo OR
    Chronobiologia; 1984; 11(4):357-79. PubMed ID: 6397339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on diabetes mellitus after ventromedial hypothalamic lesions in adult and aged rats.
    Lazaris JA; Goldberg RS; Kozlov MP
    Endocrinol Exp; 1985 Jun; 19(2):67-76. PubMed ID: 3893974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prolactin response to TRH in insulin-dependent diabetes mellitus].
    Gragnoli G; Tanganelli I; Signorini AM
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1989-95. PubMed ID: 6779839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic alcohol consumption, type 2 diabetes mellitus, insulin-like growth factor-I (IGF-I), and growth hormone (GH) in ethanol-treated diabetic rats.
    Kim SJ; Ju A; Lim SG; Kim DJ
    Life Sci; 2013 Nov; 93(21):778-82. PubMed ID: 24084046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental hypothalamic or genetic obesity in the non-insulin-dependent diabetic rat.
    Portha B; Goursot R; Giroix MH; Nicolaïdis S; Picon L
    Diabetologia; 1983 Jul; 25(1):51-5. PubMed ID: 6350084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
    Ferrero E; Casale G; Tassi G; Ciaponi A
    Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of growth hormone in the development of complications in insulin-dependent diabetes].
    Krawczuk-Rybak M; Urban M
    Padiatr Grenzgeb; 1991; 30(3):237-43. PubMed ID: 2067873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of blood insulin and growth hormone to glucose infusion in normal, psoriatic and diabetic persons.
    Hopsu-Havu VK; Terho PE; Vanha-Perttula TP; Viljanen MK
    Acta Derm Venereol; 1973; 53(1):39-44. PubMed ID: 4120806
    [No Abstract]   [Full Text] [Related]  

  • 19. Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats.
    Ma J; Ma Z; Wang J; Milne RW; Xu D; Davey AK; Evans AM
    Diabetes Obes Metab; 2007 Jul; 9(4):597-9. PubMed ID: 17587403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.